Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
Arian Emami Riedmaier, Kevin DeMent, James E. Huckle, et al.
The AAPS Journal (2020) Vol. 22, Iss. 6
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 289-331
Open Access | Times Cited: 114
Towards in vitro models for reducing or replacing the use of animals in drug testing
David M. Stresser, Anna K. Kopec, Philip Hewitt, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 8, pp. 930-935
Closed Access | Times Cited: 46
Development and Validation of an Explainable Machine Learning-Based Prediction Model for Drug–Food Interactions from Chemical Structures
Quang-Hien Kha, Viet-Huan Le, Truong Nguyen Khanh Hung, et al.
Sensors (2023) Vol. 23, Iss. 8, pp. 3962-3962
Open Access | Times Cited: 45
Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 563-576
Open Access | Times Cited: 18
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 58
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs
Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, et al.
Clinical Pharmacokinetics (2025)
Open Access | Times Cited: 1
Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs
Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, et al.
Clinical Pharmacokinetics (2025)
Closed Access | Times Cited: 1
Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New Drugs
Fang Wu, Heta Shah, Min Li, et al.
The AAPS Journal (2021) Vol. 23, Iss. 2
Closed Access | Times Cited: 50
Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles
Akshay Narula, Rayan Sabra, Na Li
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3085-3099
Open Access | Times Cited: 29
Using Mechanistic Modeling Approaches to Support Bioequivalence Assessments for Oral Products
Fang Wu, Youssef M. Mousa, Rebeka Jereb, et al.
The AAPS Journal (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 7
Machine learning methods for prediction of food effects on bioavailability: A comparison of support vector machines and artificial neural networks
Harriet Bennett-Lenane, Brendan T. Griffin, Joseph P. O’Shea
European Journal of Pharmaceutical Sciences (2021) Vol. 168, pp. 106018-106018
Open Access | Times Cited: 33
Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery
Wei Wang, Defang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2100-2120
Closed Access | Times Cited: 27
Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product Development
Di Wu, Min Li
Pharmaceutical Research (2022) Vol. 40, Iss. 2, pp. 321-336
Closed Access | Times Cited: 27
Assessment of food effects during clinical development
Zahari Vinarov, James Butler, Filippos Kesisoglou, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122758-122758
Open Access | Times Cited: 15
Physiologically Based Pharmacokinetic (PBPK) Modeling of small molecules: How Much Progress Have We Made?
Nina Isoherranen
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 5
Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms
Timothy R. Lex, Jason D. Rodriguez, Lei Zhang, et al.
The AAPS Journal (2022) Vol. 24, Iss. 2
Closed Access | Times Cited: 21
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
Abdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 5, pp. 610-618
Open Access | Times Cited: 12
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
Sivacharan Kollipara, Frederico Severino Martins, Maitri Sanghavi, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 345-358
Closed Access | Times Cited: 12
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
Christer Tannergren, Harshad Jadhav, Emma Eckernäs, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 186, pp. 144-159
Open Access | Times Cited: 11
Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration
Jelena Djuriš, Sandra Cvijić, Ljiljana Djekić
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 177-177
Open Access | Times Cited: 4
Food‐Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012‐2022
Kayla R. Tunehag, Blessy George, Sherbet Samuels, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 6, pp. 697-703
Closed Access | Times Cited: 4
A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: paving the road towards fed virtual BE studies for itraconazole amorphous solid dispersions.
Niklas Rudolph, Nitin B. Charbe, David Plano, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107047-107047
Open Access
Challenges in Predicting Colonic Luminal and Tissue Concentrations of Mesalamine and Acetyl Mesalamine Using Physiologically Based Biopharmaceutics Modeling
Harshad Jadhav, Arno Van Camp, Christer Tannergren, et al.
(2025)
Closed Access
Regulatory Perspective Based on Survey of Relationship Between Biopharmaceutical Characteristics and Food Effects on Systemic Pharmacokinetics
Naoko Honma, KAGARI YAMAGISHI, Yuki Ideno, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Challenges in predicting colonic luminal and tissue concentrations of mesalamine and acetyl mesalamine using physiologically based biopharmaceutics modeling
Harshad Jadhav, Arno Van Camp, Christer Tannergren, et al.
International Journal of Pharmaceutics (2025), pp. 125547-125547
Closed Access
Page 1 - Next Page

Scroll to top